Glenmark Pharmaceuticals Limited — Others, 25-07-2025: Copy of Newspaper Publication

Glenmark Pharma has notified shareholders about the transfer of equity shares to the Investor Education and Protection Fund (IEPF). This applies to shares where dividends have remained unclaimed for seven consecutive years or more. Shareholders with unclaimed dividends or shares should submit their claims to the company or its Registrar and Share Transfer Agent by October 15, 2025. Failure to do so will result in these shares being transferred to the IEPF Authority, after which claims must be made directly through the IEPF. A list of affected shareholders is available on the company's website.